Lilly Preparing For Increasing Mounjaro Demand On Top Of Solid Launch

 
• By Joseph Haas
  
Eli Lilly logo sign atop Lilly Biotechnology Center campus of an American pharmaceutical company Eli Lilly and Company
Tirzepatide may soon compete with semaglutide in two major indications • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business